Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|February 13, 2024
Exploring Safety in Gender-Affirming Hormonal Treatments: An Observational Study on Adverse Drug Events Using the Food and Drug Administration Adverse Event Reporting System DatabaseAinhoa Gomez-Lumbreras, Lorenzo Villa-Zapata
BMC Neurology|May 25, 2021
Risk of ischaemic stroke associated with antiepileptic drugs: a population-based case-control study in CataloniaMaria Giner-Soriano, Josep Ramon Marsal, Ainhoa Gomez-Lumbreras, et al.
BMC Primary Care|June 8, 2022
Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)Maria Giner-Soriano, Ainhoa Gomez-Lumbreras, Cristina Vedia, et al.
Rheumatology International|September 14, 2022
Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposureMalinda S Tan, Ainhoa Gomez-Lumbreras, Lorenzo Villa-Zapata, et al.
Clinical Cardiology|October 3, 2024
Nonvitamin K Anticoagulants: Risk of Bleeding When Interacting With Other Medications: A Cohort Study From MedicareAinhoa Gomez-Lumbreras, Madeline Brendle, Krystal Moorman-Bishir, et al.
Atencion Primaria|July 1, 2022
[Pharmacological treatment of the heart failure according to the ventricular ejection fraction in primary care]Maria Giner-Soriano, Dioselina Díaz Baena, Dan Ouchi, et al.
Journal of Cardiovascular Pharmacology|September 9, 2022
Risk of Bleeding Among Individuals on Direct-Acting Oral Anticoagulants: An Academic Medical Center Cohort StudyAinhoa Gomez Lumbreras, Malinda S Tan, Krystal Moorman-Bishir, et al.
International Ophthalmology|August 22, 2023
Real-world evidence in the use of Bevacizumab in age-related macular degeneration (ArMD): a scoping reviewAinhoa Gomez-Lumbreras, Priyanka Ghule, Rupesh Panchal, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|May 25, 2018
Characteristics of Apixaban-Treated Patients, Evaluation of the Dose Prescribed, and the Persistence of Treatment: A Cohort Study in CataloniaAinhoa Gomez-Lumbreras, Jordi Cortes, Maria Giner-Soriano, et al.
Leukemia & Lymphoma|September 14, 2023
Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopeniasAinhoa Gomez-Lumbreras, Santiago Mercadal Vilchez, Lorenzo Villa-Zapata, et al.
Pageof 4